Know Labs Invents New Way to Detect Blood Glucose — Non-invasively
The Future of Blood Monitoring
SEATTLE — (BUSINESS WIRE) — Know Labs, Inc. (f/k/a Visualant, Incorporated) (OTCQB: KNWN) — a provider of identification, authentication and diagnostic solutions, released today a video of the Company’s invention of a new technology to detect blood glucose non-invasively. In the video, Company CEO Phil Bosua briefly discusses the breakthrough.
The transcript of Phil Bosua’s narrative in the video states in part:
“We’re developing a brand-new technology platform that measures blood glucose — non-invasively. Our bench tests are proving to be better than expected and we’re really excited about the future.”
About Visualant, Inc.
VisualantTM is a public company whose shares trade under the stock symbol “VSUL.” The Visualant technology directs structured light or radio waves through a substance or material to capture a unique molecular signature. The Company refers to these signatures as ChromaIDTM and Bio-RFIDTM. ChromaID and Bio-RFID are used to identify, detect, or diagnose substance markers or biomarkers that may be invisible to the human eye. ChromaID and Bio-RFID scanner modules can be integrated into a variety of mobile or bench-top form factors. This patented and patent pending, award-winning technology makes it possible to effectively conduct analyses that could only previously be performed by invasive and/or large and expensive lab-based tests. For more information on Visualant, visit the company’s website at www.visualant.net.
Contact:
Name: Jordyn Theisen
Phone: 319–321–8470
Email: Jordyn@knowlabs.co
Link to Original Press Release: https://www.businesswire.com/news/home/20180711005243/en/Labs-Invents-New-Detect-Blood-Glucose--
